InsidersTradesSigma
Browse the full record of transactions filed by Weisman Harlan F, Director. Officer active across 1 companies, notably TFF Pharmaceuticals, Inc.. Aggregated, 2 disclosures have been logged. Total volume traded: €24k. The latest transaction was disclosed on 18 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations
Weisman Harlan F is a Board Member of TFF Pharmaceuticals, Inc. He participates in the governance of the company and strategic decision-making. His experience in the pharmaceutical sector is valuable in guiding the company.